Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for ...

The firm’s cost advantage is underpinned by a long runway of drilling opportunities in low-cost areas. It operates exclusively in the Permian Basin, which is the cheapest source of crude oil in the US ...